PATENT CLAIM ANALYSIS

Application Number: 16043721
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "362000"]

Abstract:
Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m 2 /g; and crystals of aripiprazole lauroxil produced by such processes.

Claim (Index 21):
A process for making a compound of Formula (A) in crystal form: wherein R a  is CH 2 OC(O)R 1  and wherein R 1  is a substituted or unsubstituted aliphatic moiety; the process comprising the steps of: (a) dissolving the compound of Formula (A) or a salt or solvate thereof in a first solvent to form a homogeneous drug solution; (b) optionally combining the drug solution with a second solvent; (c) cooling the solution; and (d) when the temperature of the solution is within the range of about 31-38\u00b0 C., further homogenizing the solution to induce formation of the compound of Formula (A) in crystal form.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14833638', '14828229', '15767966', '11281489', '14604334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6945341585231916
- 35 USC 102 Novelty (BERT): 0.5913321577708496
- Combined Prediction Score: 0.6842139584479574
- Mean Citation Score: 239.44261
- Max Citation Score: 487.66064000000006
- Similarity Product: 461.4147665948201

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test